Scientists zoom in on AIDS virus hideout

March 15, 2017
HIV-1 Virus. Credit: J Roberto Trujillo/Wikipedia

French scientists said Wednesday they had found a way to pinpoint elusive white blood cells which provide a hideout for the AIDS virus in people taking anti-HIV drugs.

Being able to spot, and one day neutralise, these "reservoir" cells has long been a holy grail in the quest to wipe out AIDS and the (HIV) that causes it.

The discovery "paves the way to a better fundamental understanding of viral reservoirs," said France's CNRS research institute, which took part in the study published in Nature.

"In the longer term, it should lead to therapeutic strategies aiming to eliminate the latent virus," it added in a statement.

There is no cure for HIV, and infected people have to take virus-suppressing drugs for life.

This is because a small number of , in a category of cell called CD4 T lymphocytes, provide a haven for the virus, enabling it to re-emerge and spread if treatment is stopped— even after decades.

In tests using the blood of HIV patients, the researchers managed to spot a protein, dubbed CD32a, on the surface of virus-infected reservoir cells.

It was absent from .

Such a "marker" has proved very difficult to find, explained AIDS researcher Douglas Richman from the University of California San Diego, who did not take part in the study.

A person infected with HIV has about 200 billion CD4 T cells, of which only one in a million act as virus reservoirs.

Two percent of the body's CD4 T cells (some four billion) are found in the approximately five litres of blood in an adult human, said Richman.

This means that a 100-millilitre blood sample would contain about 80 million CD4 T cells, of which around 80 would be virus reservoirs.

Whether CD32a plays an active part in enabling the to hole up in CD4 cells is a big question.

If so, it could throw open a tempting target for drugs to block the stealthy process.

While describing the study as "potentially seminal", Richman cautioned that CD32a was a marker found in only about half of CD4 T reservoir cells.

To eradicate latent HIV would require the targeting of a much larger proportion.

It also remains to be seen whether CD32a is as good a marker for non-blood CD4 T in the lymph nodes, bone marrow, gut and other tissues which could be reservoirs, he added.

Explore further: Immune-enhancing treatment may destabilize HIV reservoirs

More information: Benjamin Descours et al. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses, Nature (2017). DOI: 10.1038/nature21710

Related Stories

Immune-enhancing treatment may destabilize HIV reservoirs

July 21, 2016
Although antiretroviral therapy (ART) can reduce the amount of HIV in the blood to an undetectable level in most chronically infected people, it cannot eliminate reservoirs of HIV that persist in latently infected immune ...

Study observes potential breakthrough in treatment of HIV

June 17, 2016
A new study conducted by researchers at the San Francisco VA Medical Center (SFVAMC) observes that pharmacological enhancement of the immune systems of HIV patients could help eliminate infected cells, providing an important ...

HIV 'safe houses' identified

July 14, 2016
Researchers from the University of Montreal Hospital Research Center (CRCHUM) have identified cells that provide "safe houses" for the human immunodeficiency virus (HIV) during antiretroviral therapy (ART).

Targeting dormant HIV

September 19, 2016
Discovery of a novel, advanced technique to identify the rare cells where human immunodeficiency virus (HIV) hides in patients taking antiretroviral therapy (ART). This is an important step forward in the search for a HIV/AIDS ...

Targeting HIV 'reservoir' could be first step to understanding how to cure the disease

December 1, 2015
A new clinical trial will test whether it is possible to destroy hidden reservoirs of HIV virus that are a key obstacle to curing the disease.

Identification of drug combinations that reverse HIV-1 latency

March 30, 2015
There are almost 40 million people throughout the world living with HIV-1/AIDs. While current antiretroviral therapies are able to reduce the amount of virus in the blood, HIV remains present in a latent state within T cells. ...

Recommended for you

Study suggests a way to stop HIV in its tracks

December 1, 2017
When HIV-1 infects an immune cell, the virus travels to the nucleus so quickly there's not enough time to set off the cell's alarm system.

Discovery puts the brakes on HIV's ability to infect

November 30, 2017
Viewed with a microscope, the virus faintly resembles a pineapple—the universal symbol of welcome. But HIV, the virus that causes AIDS, is anything but that. It has claimed the lives of more than 35 million people so far.

Rising levels of HIV drug resistance

November 30, 2017
HIV drug resistance is approaching and exceeding 10% in people living with HIV who are about to initiate or reinitiate first-line antiretroviral therapy, according to the largest meta-analysis to date on HIV drug resistance, ...

Male circumcision and antiviral drugs appear to sharply reduce HIV infection rate

November 29, 2017
A steep drop in the local incidence of new HIV infections accompanied the rollout of a U.S.-funded anti-HIV program in a large East-African population, according to a study led by researchers at Johns Hopkins Bloomberg School ...

Combination HIV prevention reduces new infections by 42 percent in Ugandan district

November 29, 2017
A study published today in the New England Journal of Medicine provides real-world evidence that implementing a combination of proven HIV prevention measures across communities can substantially reduce new HIV infections ...

Research on HIV viral load urges updates to WHO therapy guidelines

November 24, 2017
A large cohort study in South Africa has revealed that that low-level viraemia (LLV) in HIV-positive patients who are receiving antiretroviral treatment (ART) is an important risk factor for treatment failure.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.